The International Society of Stem Cell Application has unveiled its acclaimed speakers at their mid-2023 Regenerative Medicine Conference in Pakistan, slated for June 10 and 11 at the prestigious University of Lahore (UOL).
With the invaluable presence of esteemed experts in the field and the latest discoveries and technological advances showcased all in one place, our aim is to provide an enriching experience. This conference promises to cater to the diverse needs of professionals, including those in stem cell research and aesthetic medicine, by offering opportunities for training, access to advanced equipment, and the latest updates on advancements in the field.
Besides the UOL, ISSCA is proud to collaborate with other authoritative institutions in stem cell technology in hosting this landmark conference in Pakistan: The University College of Medicine and Dentistry (UCMD) and the Academy of Aesthetic and Regenerative Medicine (AARM). The event aims to inspire physicians to incorporate regenerative medicine into their practices and enhance global access to these revolutionary services.
The conference will comprise two sections — a theoretical segment and a practical session:
The ISSCA Pakistan Conference Theoretical Segment-Meet the Renowned Expert Speakers
World-class medical experts in regenerative medicine will share their skills and experience during the theoretical session. Their invaluable insights and expertise will provide attendees with cutting-edge knowledge and practical applications of stem cell therapy. They include:
Leading the team is Benito Novas, the Managing Director of ISSCA and CEO of Global Stem Cells Group. He brings a mastery of building successful medical practices and a passion for continuously developing stem cell research and technologies. He spoke about the collaboration and his vision for the conference and ISSCA, mentioning that “ISSCA’s mission is to share regenerative medicine’s benefits worldwide, supporting patients and physicians in harnessing its power globally.”
Dr. Salih Yildirim
Dr. Yildirim, ISSCA Director of Overseas Operations and head of Middle East Operations, will also speak. Besides having a wealth of knowledge from his studies, he has headed several initiatives in the stem cell field, representing an undoubted authority. Additionally, his prowess stems from overseeing a leading biotechnology supplier of regenerative medicine products; he brings first-hand and in-depth ingenuity that’ll be valuable to the conference.
He enthusiastically expressed his eagerness to share his expertise, saying, “Regenerative medicine is a fast-paced field experiencing exponential growth with ongoing research and product advancements worldwide. We are thrilled to collaborate with esteemed institutions to host this conference.”
Other esteemed speakers include Dr. Fahad Usman, President of the Academy of Aesthetic and Regenerative Medicine and Director Center for Aesthetic Medicine at the University of Lahore (UOL); Dr. Evrim Uçkunkaya, a renowned expert in Plastic, Aesthetic, and Reconstructive Surgery in Turkey; Dr. Hilmi Karadeniz, a reputable clinic owner in Istanbul specializing in arthroscopic and spine surgery, pediatric orthopedics, and Intra-Joint Regenerative Cell Therapy (SVF); Dr. Erdinc Civelek, a Ph.D. candidate at the Health Sciences Istanbul Training and Research Hospital with expertise in stem cell research; and Dr. Serdar Kabataş, General Secretary of the Society of Stem Cell and Cellular Therapies in Turkey with education in Neural Stem Cell (NSC) from Harvard Medical School, who has led several discoveries, publications, and university lectures in the industry.
Dr. Melihcan Sezgiç, a specialist in Plastic, Reconstructive, and Aesthetic Surgery at RegenIC Clinic, ISSCA certificated instructor, and graduate from Ankara University, will also be sharing his expertise at the conference, along with other renowned doctors including Dr. Shehzad Karim Bhatti, an Interventional Radiologist & Pain Management Specialist; Dr. Naveed A Khan, a Plastic Surgeon; Dr. Zaheer Anjum, a Stem Cell & Pain Management Specialist; Dr. M Amir Sohail, an Orthopedic Surgeon; Dr. Sarfraz Ahmad Mughall, an Ophthalmologist; and Dr. Imran Haider Qaisrani, an Orthopedic Surgeon.
The ISSCA Pakistan Conference Practical Segment
The experiential part of the conference will offer participants training on clinical and aesthetic applications of stem cell therapy and the best practices for establishing a safe and efficient medical practice. Physicians and specialists will be treated to state-of-the-art technologies that shape the medical field and the latest knowledge in modern regenerative medicine products.
Final Words About the Conference
The event’s sponsors include Global Stem Cells Group, University College of Medicine and Dentistry (UCMD),Biotrend, and N-Biotek, and we at ISSCA couldn’t express our gratitude enough for this support.
Regenerative medicine is not new; nonetheless, it’s rapidly growing with continuous explorations revealing new protocols and products. The line-up of proficient speakers, high-tech equipment, and hands-on interactions should keep participants updated with the industry’s most recent changes and advancements. It should also empower them to explore more opportunities and offer a chance to be part of a valuable stem cell community. There’s more to learn about ISSCA and advancements in stem cell therapy; visit our website or email us at firstname.lastname@example.org to stay in the know.
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of the International Stem Cell Certification Agency (ISSCA) is to establish itself as a global leader in regenerative medicine certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.